Novel Calculator to Estimate Overall Survival Benefit from Neoadjuvant Chemoradiation in Patients with Esophageal Adenocarcinoma

Emmanuel Gabriel; Kristopher Attwood; Rupen Shah; Steven Nurkin; Steven Hochwald; Moshim Kukar

doi:10.1016/j.jamcollsurg.2017.01.043

Novel Calculator to Estimate Overall Survival Benefit from Neoadjuvant Chemoradiation in Patients with Esophageal Adenocarcinoma

Journal of the American College of Surgeons ◽

10.1016/j.jamcollsurg.2017.01.043 ◽

2017 ◽

Vol 224 (5) ◽

pp. 884-894.e1 ◽

Cited By ~ 9

Author(s):

Emmanuel Gabriel ◽

Kristopher Attwood ◽

Rupen Shah ◽

Steven Nurkin ◽

Steven Hochwald ◽

...

Keyword(s):

Overall Survival ◽

Esophageal Adenocarcinoma ◽

Survival Benefit ◽

Neoadjuvant Chemoradiation ◽

Overall Survival Benefit

Download Full-text

Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation

JAMA Surgery ◽

10.1001/jamasurg.2015.4068 ◽

2016 ◽

Vol 151 (3) ◽

pp. 234 ◽

Cited By ~ 14

Author(s):

Emmanuel Gabriel ◽

Kristopher Attwood ◽

William Du ◽

Rebecca Tuttle ◽

Raed M. Alnaji ◽

...

Keyword(s):

Overall Survival ◽

Esophageal Adenocarcinoma ◽

Survival Benefit ◽

Neoadjuvant Chemoradiation ◽

Node Negative ◽

Overall Survival Benefit

Download Full-text

Faculty Opinions recommendation of Persistent overall survival benefit and no increased risk of second malignancies with bortezomib-melphalan-prednisone versus melphalan-prednisone in patients with previously untreated multiple myeloma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969441.793468990 ◽

2013 ◽

Author(s):

Steven Le Gouill ◽

Cyrille Touzeau

Keyword(s):

Multiple Myeloma ◽

Overall Survival ◽

Survival Benefit ◽

Second Malignancies ◽

Increased Risk ◽

Overall Survival Benefit

Download Full-text

Faculty Opinions recommendation of Surgical resection provides an overall survival benefit for patients with small pancreatic neuroendocrine tumors.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727546585.793531209 ◽

2017 ◽

Author(s):

Christos Dervenis ◽

Dionysia Kelgiorgi

Keyword(s):

Overall Survival ◽

Surgical Resection ◽

Neuroendocrine Tumors ◽

Survival Benefit ◽

Pancreatic Neuroendocrine Tumors ◽

Overall Survival Benefit

Download Full-text

Analysis of Overall Survival Benefit of Abemaciclib Plus Fulvestrant in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer

JAMA Oncology ◽

10.1001/jamaoncol.2020.1513 ◽

2020 ◽

Vol 6 (7) ◽

pp. 1121

Author(s):

Ryan Sun ◽

Dae Hyun Kim ◽

Lee-Jen Wei

Keyword(s):

Breast Cancer ◽

Overall Survival ◽

Hormone Receptor ◽

Survival Benefit ◽

Hormone Receptor Positive ◽

Overall Survival Benefit

Download Full-text

Longer follow-up of randomized trials on adjuvant radiotherapy for breast cancer stresses the overall survival benefit due to radiotherapy

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(01)02025-9 ◽

2001 ◽

Vol 51 (3) ◽

pp. 109-110 ◽

Cited By ~ 1

Author(s):

J. Van de Steene ◽

V. Vinh-Hung ◽

G. Storme

Keyword(s):

Breast Cancer ◽

Overall Survival ◽

Adjuvant Radiotherapy ◽

Survival Benefit ◽

Randomized Trials ◽

Overall Survival Benefit

Download Full-text

Abstract P3-14-24: Overall Survival Benefit Observed with Lapatinib (L) Plus Paclitaxel (P) as First-Line Therapy in Patients with HER2-Overexpressing Metastatic Breast Cancer (MBC)

10.1158/0008-5472.sabcs10-p3-14-24 ◽

2010 ◽

Cited By ~ 4

Author(s):

Z-z Guan ◽

B-h Xu ◽

W Arpornwirat ◽

Z-s Tong ◽

V Lorvidhaya ◽

...

Keyword(s):

Breast Cancer ◽

Overall Survival ◽

Metastatic Breast Cancer ◽

Survival Benefit ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Overall Survival Benefit

Download Full-text

Partial resection offers an overall survival benefit over biopsy in MGMT-unmethylated IDH-wildtype glioblastoma patients

Surgical Oncology ◽

10.1016/j.suronc.2020.10.016 ◽

2020 ◽

Vol 35 ◽

pp. 515-519

Author(s):

Giorgio Hallaert ◽

Harry Pinson ◽

Dimitri Vanhauwaert ◽

Caroline Van den Broecke ◽

Dirk Van Roost ◽

...

Keyword(s):

Overall Survival ◽

Survival Benefit ◽

Partial Resection ◽

Overall Survival Benefit

Download Full-text

Overall Survival Benefit with Sipuleucel-T by Baseline Prostate-Specific Antigen (PSA): An Exploratory Analysis from Three Phase 3 Trials

Annals of Oncology ◽

10.1016/s0923-7534(20)33500-6 ◽

2012 ◽

Vol 23 ◽

pp. ix310

Author(s):

P. Kantoff ◽

G. Chodak ◽

R.B. Sims ◽

J.B. Whitmore ◽

P. Schellhammer

Keyword(s):

Overall Survival ◽

Prostate Specific Antigen ◽

Survival Benefit ◽

Specific Antigen ◽

Exploratory Analysis ◽

Phase 3 ◽

Three Phase ◽

Overall Survival Benefit

Download Full-text

Age matters when predicting overall survival benefit of combined chemotherapy and radiation versus radiation alone in high risk endometrial cancer: A study of 20,000 women using PORTEC-3 criteria

Gynecologic Oncology ◽

10.1016/j.ygyno.2020.06.020 ◽

2020 ◽

Vol 159 ◽

pp. 11

Author(s):

Y. Casablanca ◽

C. Tian ◽

M.A. Powell ◽

B. Winterhoff ◽

J.K. Chan ◽

...

Keyword(s):

Overall Survival ◽

Endometrial Cancer ◽

High Risk ◽

Survival Benefit ◽

Combined Chemotherapy ◽

Overall Survival Benefit

Download Full-text

Overall survival benefit for weekly vs. three-weekly taxanes regimens in advanced breast cancer: A meta-analysis

Cancer Treatment Reviews ◽

10.1016/j.ctrv.2009.10.006 ◽

2010 ◽

Vol 36 (1) ◽

pp. 69-74 ◽

Cited By ~ 62

Author(s):

Davide Mauri ◽

Konstantinos Kamposioras ◽

Lamprini Tsali ◽

Magdalini Bristianou ◽

Antonis Valachis ◽

...

Keyword(s):

Breast Cancer ◽

Overall Survival ◽

Advanced Breast Cancer ◽

Survival Benefit ◽

Meta Analysis ◽

Advanced Breast ◽

Overall Survival Benefit

Download Full-text